Andrew J. Armanino, Director at Better Therapeutics, Inc. (BTTX), bought 42,000 shares at $5.48 ($230K) on 2021-12-13, disclosed to the SEC on 2021-12-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.48 | 21,000 | $115K | 50.0% |
| 2 | $5.48 | 21,000 | $115K | 50.0% |
| Total | $5.48 avg | 42,000 | $230K | 100% |
| Filing → |
| BTTX | BUY | 2023-04-12 | $503K | — | Filing → |
| BTTX | BUY | 2022-06-16 | $21K | — | Filing → |
| BTTX | BUY | 2022-06-10 | $41K | — | Filing → |